CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BIIB's Revenue Growth by Quarter and Year

Biogen Inc 's Revenue results by quarter and year




BIIB Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 2,852.60 3,671.30 3,526.30 3,307.00
III Quarter September 3,376.10 3,600.10 3,439.00 3,077.80
II Quarter June 3,681.60 3,616.70 3,356.50 3,078.40
I Quarter March 3,534.30 3,489.80 3,131.10 2,810.70
FY   13,444.60 14,377.90 13,452.90 12,273.90



BIIB Revenue forth quarter 2020 Y/Y Growth Comment
Biogen Inc reported decline in Revenue in the forth quarter by -22.3% to $ 2,852.60 millions, from the same quarter in 2019.
This represents worst decline in recent Company history.

Looking into forth quarter results within Biotechnology & Drugs industry 66 other companies have achieved higher Revenue growth. While Biogen Inc ' s Revenue fall of -22.3% ranks overall at the positon no. 2645 in the forth quarter.




BIIB Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December -22.3 % 4.11 % 6.63 % 15.15 %
III Quarter September -6.22 % 4.68 % 11.74 % 4.13 %
II Quarter June 1.79 % 7.75 % 9.03 % 6.36 %
I Quarter March 1.28 % 11.46 % 11.4 % 3.08 %
FY   -6.49 % 6.88 % 9.61 % 7.21 %

Financial Statements
Biogen Inc 's forth quarter 2020 Revenue $ 2,852.60 millions BIIB's Income Statement
Biogen Inc 's forth quarter 2019 Revenue $ 3,671.30 millions Quarterly BIIB's Income Statement
New: More BIIB's historic Revenue Growth >>


BIIB Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December -15.51 % 1.98 % 2.54 % 7.45 %
III Quarter September -8.3 % -0.46 % 2.46 % -0.02 %
II Quarter June 4.17 % 3.64 % 7.2 % 9.52 %
I Quarter March -3.73 % -1.04 % -5.32 % -2.13 %
FY (Year on Year)   -6.49 % 6.88 % 9.61 % 7.21 %




Revenue forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #67
Healthcare Sector #361
Overall #2645

Revenue Y/Y Growth Statistics
High Average Low
96.03 % 13.82 % -22.3 %
(Dec. 31, 2004)   (Dec 31 2020)
Revenue forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #67
Healthcare Sector #361
Overall #2645
Revenue Y/Y Growth Statistics
High Average Low
96.03 % 13.82 % -22.3 %
(Dec. 31, 2004)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Biogen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
80.67 % 3.81 % -15.51 %
(March 31, 2004)  


BIIB's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2020 Biogen Inc realized fall in Revenue sequentially by -15.51% to $ 2,852.60 millions, from $ 3,376.10 millions declared in the previous reporting period.

Even periodic influence were not able to rescue the IV. Quarter for the Biogen Inc , Aarush Khan , Healthcare sector researcher wrote.

Within Biotechnology & Drugs industry 75 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 2772.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #76
Healthcare Sector #374
Overall #2772
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #76
Healthcare Sector #374
Overall #2772
Revenue Q/Q Growth Statistics
High Average Low
80.67 % 3.81 % -15.51 %
(March 31, 2004)  


BIIB's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2020 Biogen Inc disclosed fall in Revenue sequentially by -15.51% to $ 2,852.60 millions, from $ 3,376.10 millions achived in the previous quarter.

Although cyclical influence commonly fuel IV. Quarter 2020 Revenue, this clearly was not substantial to salvage Biotechnology & Drugs's company IV. Quarter 2020 performance, Aarush Khan , Healthcare sector researcher pointed out.

Within Biotechnology & Drugs industry 75 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 2772.


Biogen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Revenue 12 Months Ending $ 13,444.60 $ 14,263.30 $ 14,487.30 $ 14,422.40 $ 14,377.90
Y / Y Revenue Growth (TTM) -6.49 % 0.21 % 2.95 % 4.42 % 6.88 %
Year on Year Revenue Growth Overall Ranking # 1609 # 1655 # 53 # 1547 # 1266
Seqeuential Revenue Change (TTM) -5.74 % -1.55 % 0.45 % 0.31 % 1.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 2868 # 2396 # 35 # 1639 # 1590




Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Biogen Inc reported a decrease in Revenue by -6.49% year on year, to $13,445 millions, compare to the 0.21% growth at Sep 30 2020.

In the Healthcare sector 245 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1609, from total ranking in previous quarter at 1655.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.31 %
2.95 %
-5.74 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 83
Healthcare Sector # 246
Overall # 1609

Revenue TTM Y/Y Growth Statistics
High Average Low
41.42 %
13.27 %
-6.49 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 83
Sector # 402
S&P 500 # 2868
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Biogen Inc reported a decrease in Revenue by -6.49% year on year, to $13,445 millions, compare to the 0.21% growth at Sep 30 2020.

In the Healthcare sector 245 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1609, from total ranking in previous quarter at 1655.

Revenue TTM Q/Q Growth Statistics
High Average Low
10.31 %
2.95 %
-5.74 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 83
Healthcare Sector # 246
Overall # 1609

Revenue TTM Y/Y Growth Statistics
High Average Low
41.42 %
13.27 %
-6.49 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 83
Sector # 402
S&P 500 # 2868




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIIB's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BIIB's Competitors
Revenue Growth for Biogen Inc 's Suppliers
Revenue Growth for BIIB's Customers

You may also want to know
BIIB's Annual Growth Rates BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Regenerx Biopharmaceuticals Inc-0.01%$ -0.005 millions
Orthopediatrics Corp-0.15%$ -0.148 millions
Icon Plc-0.30%$ -0.305 millions
Precision Optics Corporation Inc -0.40%$ -0.404 millions
Bausch Health Companies Inc -0.49%$ -0.495 millions
Biomarin Pharmaceutical Inc-0.51%$ -0.512 millions
Endo International Plc-0.60%$ -0.599 millions
Sanofi-0.70%$ -0.696 millions
Stereotaxis Inc -0.99%$ -0.987 millions
Apollo Medical Holdings Inc -1.10%$ -1.101 millions
Prestige Consumer Healthcare Inc -1.14%$ -1.144 millions
Accuray Incorporated-1.38%$ -1.383 millions
Surmodics Inc -1.41%$ -1.411 millions
Integra Lifesciences Holdings Corp-1.64%$ -1.640 millions
Zimmer Biomet Holdings Inc -1.90%$ -1.901 millions
Rockwell Medical inc -2.10%$ -2.103 millions
Delcath Systems Inc -2.12%$ -2.124 millions
Sientra inc -2.44%$ -2.439 millions
Fonar Corp-2.44%$ -2.442 millions
Corcept Therapeutics Inc-2.46%$ -2.457 millions
Avanos Medical Inc -2.53%$ -2.529 millions
Arcus Biosciences Inc -2.70%$ -2.697 millions
Pacific Biosciences Of California Inc -2.84%$ -2.843 millions
Orthofix Medical Inc -3.19%$ -3.189 millions
Cutera Inc-3.58%$ -3.576 millions
Lifevantage Corp-3.65%$ -3.649 millions
Phibro Animal Health Corp-3.67%$ -3.674 millions
Taro Pharmaceutical Industries Ltd-3.75%$ -3.750 millions
Invacare Corporation-3.81%$ -3.808 millions
China Pharma Holdings Inc -3.85%$ -3.848 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBLI's Profile

Stock Price

CBLI's Financials

Business Description

Fundamentals

Charts & Quotes

CBLI's News

Suppliers

CBLI's Competitors

Customers & Markets

Economic Indicators

CBLI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071